ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
China tech

China startup finds growth with $765 cancer-screening kit

Genetron rides COVID tailwind as health awareness rises and population ages

Genetron has developed easy-to-use cancer screening test kits, which can be purchased on e-commerce sites. (Source photos by Daiki Katagiri and Genetron Health)

GUANGZHOU, China -- A Chinese startup that provides cancer risk diagnosis and other services is showing rapid growth as the country's aging population, shocked by the novel coronavirus, is beginning to take its health more seriously.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more